Five Critical Challenges in Investigator Site Selection and How Clinical Data Science Can Solve Them
Poor investigator site selection remains a significant driver of spiraling costs and inefficiencies in clinical development.
Gen Li, PhD, MBA
Advertisement
Articles by Gen Li, PhD, MBA
Pharmaceutical Executive
A discussion of the cost and time put into clinical trials.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: AbbVie and Haisco Enter $745 Million Licensing Agreement
2
Travere Therapeutics’ Filspari Receives Full FDA Approval
3
How Serious is the Biosimilar Void?
4
How Are Regulatory Factors Impacting Biosimilars
5